Parkinson's Neuropsychometric Dementia Assessment

from Wikipedia, the free encyclopedia

The Parkinson Neuropsychometric Dementia Assessment ( acronym : PANDA ) is a screening tool for cognitive impairment and dementia in people with Parkinson's disease . Both mild cognitive impairment in Parkinson's disease (PD-MCI) and Parkinson's dementia (PDD) have a high prevalence in the course of the disease.

The test comprises five tasks on cognitive performance and three questions on possible symptoms of depression (mood, interest, drive).

A maximum of 30 points can be achieved. A normal cognitive performance corresponds to ≥18 points, while in the range of 15–17 points there are indications of a slight cognitive dysfunction and in the range of ≤ 14 points indications of dementia. The sensitivity for the detection of Parkinson's dementia is 91%, the specificity 90%. The test takes about 10 minutes.

Individual evidence

  1. ↑ a b c Elke Kalbe , Pasquale Calabrese , Nils Kohn, Rüdiger Hilker, Oliver Riedel, Hans-Ulrich Wittchen , Richard Dodel , Jörg Otto, Georg Ebersbach, Josef Kessler : Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment ( PANDA) instrument. In: Parkinsonism & Related Disorders. 14, 2008, pp. 93-101, doi : 10.1016 / j.parkreldis.2007.06.008 .
  2. ↑ Andreas Hufschmidt et al. (Ed.): Neurology compact. 7th edition, Thieme 2017, ISBN 978-3131171979 , p. 398.
  3. ↑ a b Elke Kalbe, Pasquale Calabrese, Sophie Fengler, Josef Kessler: DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity. In: Journal of Alzheimer's Disease. 34, 2013, pp. 813-834, doi : 10.3233 / jad-122128 .